Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils

Journal of Immunology

Volumn 175, Issue 8, 2005, Pages 5439-5447

  Inoue, Yoshinari ^a   Matsuwaki, Yoshinori ^a   Shin, Seung Heon ^a   Ponikau, Jens U ^a   Kita, Hirohito ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD11B ANTIGEN; CD63 ANTIGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PERTUSSIS TOXIN; THROMBOCYTE ACTIVATING FACTOR;

ALLERGIC DISEASE; ALTERNARIA ALTERNATA; ARTICLE; ASPERGILLUS; ASTHMA; CALCIUM CELL LEVEL; CANDIDA ALBICANS; CELL ACTIVATION; CELL SURFACE; CLADOSPORIUM; CONTROLLED STUDY; CURVULARIA; DEGRANULATION; DRECHSLERA SOROKINIANA; ENVIRONMENTAL EXPOSURE; EOSINOPHIL; EXOCYTOSIS; FUNGUS; HOST RESISTANCE; HUMAN; HUMAN CELL; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; MACROPHAGE; NONHUMAN; PATHOPHYSIOLOGY; PENICILLIUM; PRIORITY JOURNAL;

EID: 26844488833     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.8.5439     Document Type: Article

References (58)

1. Gleich, G. J., and C. R. Adolphson. 1986. The eosinophilic leukocyte: structure and function. Adv. Immunol. 39: 177-253.
2. Kita, H., C. R. Adolphson, and G. J. Gleich. 2003. Biology of eosinophils. In Middleton's Allergy: Principles and Practice, Vol. 1, 6th Ed. N. F. Adkinson, Jr., B. S. Bochner, J. W. Yunginger, S. T. Holgate, W. W. Busse, and F. E. R. Simons, eds. Mosby, St. Louis, pp. 305-332.
3. Gleich, G. J., E. Frigas, D. A. Loegering, D. L. Wassom, and D. Steinmuller. 1979. Cytotoxic properties of eosinophil major basic protein. J. Immunol. 123: 2925-2927.
4. Ayars, G. H., L. C. Altman, G. J. Gleich, D. A. Loegering, and C. B. Baker. 1985. Eosinophil- and eosinophil granule-mediated pneumocyte injury. J. Allergy Clin. Immunol. 76: 595-604.
5. Gleich, G. J. 1990. The eosinophil and bronchial asthma: Current understanding. J. Allergy Clin. Immunol. 85: 422-436.
6. Motojima, S., E. Frigas, D. A. Loegering, and G. J. Gleich. 1989. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am. Rev. Respir. Dis. 139: 801-805.
7. Brofman, J. D., S. R. White, J. S. Blake, N. M. Munoz, G. J. Gleich, and A. R. Leff. 1989. Epithelial augmentation of trachealis contraction caused by major basic protein of eosinophils. J. Appl. Physiol. 66: 1867-1873.
8. Gundel, R. H., L. G. Letts, and G.J. Gleich. 1991. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J. Clin. Invest. 87: 1470-1473.
9. Filley, W. V., K. E. Holley, G. M. Kephart, and G. J. Gleich. 1982. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet 2: 11-16.
10. Ponikau, J. U., D. A. Sherris, G. M. Kephart, E. B. Kern, D. J. Congdon, C. R. Adolphson, M. J. Springett, G. J. Gleich, and H. Kita. 2005. Striking deposition of toxic eosinophil major basic protein in mucus: Implications for chronic rhinosinusitis. J. Allergy Clin. Immunol. 116: 362-369.
11. Leiferman, K. M., S. J. Ackerman, H. A. Sampson, H. S. Haugen, P. Y. Venencie, and G. J. Gleich. 1985. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis: comparison with onchocerciasis. N. Engl. J. Med. 313: 282-285.
12. Matthews, A. N., D. S. Friend, N. Zimmermann, M. N. Sarafi, A. D. Luster, E. Pearlman, S. E. Wert, and M. E. Rothenberg. 1998. Eotaxin is required for the baseline level of tissue eosinophils. Proc. Natl. Acad. Sci. USA 95: 6273-6278.
13. Kita, H., M. Kaneko, K. R. Bartemes, D. A. Weiler, A. W. Schimming, C. E. Reed, and G. J. Gleich. 1999. Does IgE bind to and activate eosinophils from patients with allergy? J. Immunol. 162: 6901-6911.
14. Seminario, M. C., S. S. Saini, D. W. MacGlashan, Jr., and B. S. Bochner. 1999. Intracellular expression and release of FcεRIα by human eosinophils. J. Immunol. 162: 6893-6900.
15. Abu-Ghazaleh, R. I., T. Fujisawa, J. Mestecky, R. A. Kyle, and G. J. Gleich. 1989. IgA-induced eosinophil degranulation. J. Immunol. 142: 2393-2400.
16. Khalife, J., M. Capron, J. Y. Cesbron, P. C. Tai, H. Taelman, L. Prin, and A. Capron. 1986. Role of specific IgE antibodies in peroxidase (EPO) release from human eosinophils. J. Immunol. 137: 1659-1664.
17. Kroegel, C., T. Yukawa, G. Dent, P. Venge, K. F. Chung, and P. J. Barnes. 1989. Stimulation of degranulation from human eosinophils by platelet-activating factor. J. Immunol. 142: 3518-3526.
18. Elsner, J., R. Hochstetter, D. Kimmig, and A. Kapp. 1996. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur. J. Immunol. 26: 1919-1925.
19. Mahmudi-Azer, S., G. P. Downey, and R. Moqbel. 2002. Translocation of the tetraspanin CD63 in association with human eosinophil mediator release. Blood 99: 4039-4047.
20. Kernen, P., M. P. Wymann, V. von Tscharner, D. A. Deranleau, P. C. Tai, C. J. Spry, C. A. Dahinden, and M. Baggiolini. 1991. Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils. J. Clin. Invest. 87: 2012-2017.
21. Bach, M. K., and J. R. Brashler. 1992. FMLP is a potent activator of guinea-pig eosinophils but its activity is dependent on the prior overnight in vitro culture of the cells (facilitation). Immunology 75: 680-687.
22. van Burik, J. A., and P. T. Magee. 2001. Aspects of fungal pathogenesis in humans. Annu. Rev. Microbiol. 55: 743-772.
23. H. F. Kaufman, J. F. Tomee, T. S. van der Werf, J. G. de Monchy, and G. K. Koeter. 1995. Review of fungus-induced asthmatic reaction. Am. J. Respir. Crit. Care Med. 151:2109-2115.
24. Tomee, J. P., and H. F. Kaufman. 2000. Putative virulence factors of Aspergillus fimigatus. Clin. Exp. Allergy 30: 476-484.
25. Kherdmand, F., A. Kiss, J. Xu, S. H. Lee, P. E. Kolattukudy, and D. B. Corry. 2002. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J. Immunol. 169: 5904-5911.
26. Bush, R. K., and J. J. Prochnau. 2004. Case study: Alternaria-induced asthma. J. Allergy Clin. Immunol. 113: 227-234.
27. Dill, I., and B. Niggemann. 1996. Domestic fungal viable propagules and sensitization in children with IgE mediated allergic diseases. Pediatr. Allergy Immunol. 7: 151-155.
28. Li, C. S., and L. Y. Hsu. 1997. Airborne fungus allergen in association with residential characteristics in atopic and control children in a subtropical region. Arch. Environ. Health 52: 72-79.
29. Aas, K., J. Leegard, L. Aukrust, and O. Grimmer. 1980. Immediate type hyper-sensitivity to common moulds: a comparison of different diagnostic materials. Allergy 35: 443-451.
30. O'Hollaren, M. T., J. W. Yunginger, K. P. Offord, M. J. Somers, E. J. O'Connell, D. J. Ballard, and M. I. Sachs. 1991. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N. Engl. J. Med. 324: 359-363.
31. Hansel, T. T., I. J. De Vries, T. Iff, S. Rihs, M. Wandzilak, S. Betz, K. Blaser, and C. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods 145: 105-110.
32. Horie, S., and H. Kita. 1994. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. J. Immunol. 152: 5457-5467.
33. Wagner, J. M., K. Bartemes, K. K. Vernof, S. Dunnette, K. P. Offord, J. L. Checkel, and G. J. Gleich. 1993. Analysis of pregnancy-associated major basic protein levels throughout gestation. Placenta 14: 671-681.
34. Rabinovitch, P. S., C. H. June, A. Grossmann, and J. A. Ledbetter, 1986. Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3: simultaneous use of indo-1 and immunofluorescence with flow cytometry. J. Immunol. 137: 952-961.
35. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450.
36. Logan, M. R., S. O. Odemuyiwa, and R. Moqbel. 2003. Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion. J. Allergy Clin. Immunol. 111: 923-932.
37. 2+-ATPaSe. Proc. Natl. Acad. Sci. USA 87: 2466-2470.
38. Braun, R. K., M. Franchini, F. Erard, S. Rihs, I. J. De Vries, K. Blaser, T. T. Hansel, and C. Walker. 1993. Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore. Eur. J. Immunol. 23: 956-960.
39. Kroegel, C., M. C. Liu, W. C. Hubbard, L. M. Lichtenstein, and B. S. Bochner. 1994. Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid production. J. Allergy Clin. Immunol. 93: 725-734.
40. Nagase, H., S. Okugawa, Y. Ota, M. Yamaguchi, H. Tomizawa, K. Matsushima, K. Ohta, K. Yamamoto, and K. Hirai. 2003. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J. Immunol. 171: 3977-3982.
41. Kobayashi, T., M. H. Beuchat, M. Lindsay, S. Frias, R. D. Palmiter, H. Sakuraba, R. G. Parton, and J. Gruenberg. 1999. Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat. Cell. Biol. 1: 113-118.
42. Cham, B. P., J. M. Gerrard, and D. F. Bainton. 1994. Granulophysin is located in the membrane of azurophilic granules in human neutrophils and mobilizes to the plasma membrane following cell stimulation. Am. J. Pathol. 144: 1369-1380.
43. Kato, M., H. Kimura, Y. Motegi, A. Tachibana, H. Minakami, A. Morikawa, and H. Kita. 2002. Platelet-activating factor activates two distinct effector pathways in human eosinophils. J. Immunol. 169: 5252-5259.
44. Richardson, R. M., B. Haribabu, H. Ali, and R. Snyderman. 1996. Cross-desensitization among receptors for platelet activating factor and peptide chemoattractants: evidence for independent regulatory pathways. J. Biol. Chem. 271: 28717-28724.
45. Grady, E. P., S. K. Bohm, and N. W. Bunnett. 1997. Turning off the signal: mechanisms that attenuate signaling by G protein-coupled receptors. Am. J. Physiol. 273: G586-G601.
46. Solomon, W. R. 1975. Assessing fungus prevalence in domestic interiors. J. Allergy Clin. Immunol. 56: 235-242.
47. Mitakakis, T. Z., C. Barnes, and E. R. Tovey. 2001. Spore germination increases allergen release from Alternaria. J. Allergy Clin. Immunol. 107: 388-390.
48. Halonen, M., D. A. Stern, A. L. Wright, L. M. Taussig, and F. D. Martinez. 1997. Alternaria as a major allergen for asthma in children raised in a desert environment. Am. J. Respir. Crit. Care Med. 155: 1356-1361.
49. Zureik M., C. Neukirch, B. Leynaert, R. Liard, J. Bousquet, F. Neukirch, and European Community Respiratory Health Survey. 2002. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. Br. Med. J. 325: 411-414.
50. Black, P. N., A. A. Udy, and S. M. Brodie. 2000. Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy 55: 501-504.
51. Kaufman, H. F., J. F. Tomee, M. A. van de Riet, A. J. Timmerman, and P. Borger. 2000. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J. Allergy Clin. Immunol. 105: 1185-1193.
52. Miike, S., A. S. McWillam, and H. Kita. 2001. Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2. J. Immunol. 167: 6615-6622.
53. Steinhoff, M., J. Buddenkotte, V. Shpacovitch, A. Rattenholl, C. Moormann, N. Vergnolle, T. A. Luger, and M. D. Hollenberg. 2005. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr. Rev. 26: 1-43.
54. Al-Ani, B., M. Saifeddine, S. J. Wijesuriya, and M. D. Hollenberg. 2002. Modified proteinase-activated receptor-1 and -2 derived peptides inhibit proteinase-activated receptor-2 activation by trypsin. J. Pharmacol. Exp. Ther. 300: 702-708.
55. Williams, D. L. 1997. Overview of (1→3)-β-D-glucan immunobiology. Mediat. Inflamm. 6: 247-250.
56. D'Souza, M. P., J. S. Cairns, and S. F. Plaeger. 2000. Current evidence and future directions for targeting HIV entry: therapeutic and prophylactic strategies. J. Am. Med. Assoc. 284: 215-222.
57. Yoganathan, K., C. Rossant, S. Ng, Y. Huang, M. S. Butler, and A. D. Buss. 2003. 10-Methoxydihydrofuscin, fuscinarin, and fuscin, novel antagonists of the human CCR5 receptor from Oidiodendron griseum. J. Nat. Prod. 66: 1116-117.
58. Romani, L. 2004. Immunity to fungal infections. Nat. Rev. Immunol. 4: 1-13.